AZACITIDIN Accord subst sèche 100 mg flac
7680667700012
CH-66770
L01BC07
07.16.1.
Reimbursement limitations:
VIDAZA2
Traitement des patients non éligibles pour une transplantation de cellules souches hématopoïétiques et présentant l’un …
1 / 3
google
Details
- Product number
- 6677001
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- azacitidinum 100 mg, mannitolum, pro vitro.
Articles (1)
Azacitidin Accord 100 mg, Pulver zur Herstellung einer Injektionssuspension
Pulver zur Herstellung einer Injektionssuspension
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 259.95
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/02/2019
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 66770
- Drug name
- Azacitidin Accord, Pulver zur Herstellung einer Injektionssuspension
- Galenic form
- PULPA
- ATC Code
- L01BC07
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 28/11/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- AZACITIDIN Accord subst sèche 100 mg flac
- Description (DE)
- AZACITIDIN Accord Trockensub 100 mg Durchstf
- Market launch
- 28/11/2018
- Narcotic (BTM)
- No